A study shows that unambiguous radiologic extranodal extension, as determined by MRI, can assist clinical physicians in identifying metastatic prostate cancer patients with an area under the curve value of 0.915 using 68 Ga-PSMA PET/CT. This evidence concerns the gene FOLH1 and metastatic prostate carcinoma.